期刊文献+

暴发性1型糖尿病与经典1型糖尿病临床特征比较 被引量:4

Comparison in clinical characteristics between fulminant type 1 diabetes and classical type 1 diabetes
下载PDF
导出
摘要 目的分析暴发性1型糖尿病(fulminant type 1 diabetes,FT1DM)与经典1型糖尿病(T1DM)的临床特征,以指导临床治疗。方法回顾性分析该院内分泌科2008年12月—2014年8月间以酮症酸中毒起病的暴发型1型糖尿病患者9例(FT1DM组)和初诊经典1型糖尿病患者23例(T1DM组)的临床特征,包括起病时间、年龄、性别、体重指数、流感样症状、妊娠人数、腹痛、入院时随机血糖、糖化血红蛋白、C肽、肌酐、血钾、动脉血p H、白细胞计数等,并用t检验和χ2检验分别对计量资料和计数资料进行统计分析。结果与经典1型糖尿病相比,暴发性1型糖尿病的年龄较大,起病时间明显缩短,入院时血糖更高,糖化血红蛋白较低,胰岛功能更差,血糖达标时间延长,妊娠期女性更多(P<0.05);暴发性1型糖尿病组患者较经典1型糖尿病组患者入院时肌酐及谷草转氨酶显著升高,血钠水平降低,酸中毒明显(均P<0.05或P<0.01)。结论暴发性1型糖尿病患者起病更急,代谢紊乱更严重,熟悉其临床特征有利于早期临床治疗,改善预后。 Objective To analyze the clinical features of fulminant type 1 diabetes (FT1 DM)and classical type 1 diabetes and to guide the clinical treatment.Methods Retrospective analysis was made of the patients admitted to The Second Affiliated Hospital of Anhui Medical University from December 2008 to August 2014 with the onset of the ketoacidosis,9 cases of patients with fulminant type 1 dia-betes (FT1 DM group)and 23 cases of patients with classical type 1 diabetes (T1 DM group).Clinical features including onset time, age,gender,body mass index,flu-like symptoms,the number of pregnancy,abdominal pain,blood glucose,HbA1 C,C peptide,creati-nine,blood potassium,blood gas analysis,blood white cell count,et al.were analyzed.χ2 or t test was used for data analysis.Results In comparison with T1DMgroup,the age and the blood glucose of FT1DMgroup were higher,the onset time was shorter,the HbA1C and C peptide was lower,the time of the blood glucose reaching the standard was longer,the number of pregnant women was more (P〈0.05).The creatinine of the FT1DMgroup was higher than the T1DMgroup,the aspartate aminotransferase was also increased,blood sodium was lower,and ketoacidosis was more serious(P〈0.05 or P〈0.01 ).Conclusion Fulminant type 1 diabetes showed shorter onset time and severer metabolic derangements than classic type 1 diabetes.Being familiar with the clinical features can help us to treat it in time,and improve the prognosis of patients.
出处 《安徽医药》 CAS 2015年第6期1099-1102,共4页 Anhui Medical and Pharmaceutical Journal
基金 安徽省自然科学基金(No 12070403068)
关键词 糖尿病 1 暴发性 临床特征 fulminant clinical characteristics
  • 相关文献

参考文献2

二级参考文献19

  • 1Taniyama M, Katsumata R, Aoki K, et al. A Fillipino patient with fulminant type 1 diabetes. Diabetes Care, 2004, 27:842-843.
  • 2Imagawa A,- Hanafusa T, Uchigata Y, et al. Different contribution of class Ⅱ HLA in fulminant and typical autoimmune type 1 diabetes mellitus. Diabetologia,2005, 48:294-300.
  • 3Imagawa A, Hanafusa T, Makino H, et al. High titres of IgA antibodies to enterovirus in fulminant type-1 diabetes. Diabetologia,2005, 48:290-293.
  • 4Yadav D, Nair S, Norkus EP, et al. Nonspecitic hyperamylasemia and hyperlipasemia in diabetic ketoacidosis: incidence and correlation with biochemical abnormalities. Am J Gastroenterol,2000, 95:3123-3128.
  • 5Semakula C, Vandewalle CL, Van Schravendijk CF, et al.Abnormal pancreatic enzyme activities in more than twenty-five percent recent onset insulin-dependent diabetic patients: association of hyperlipasemia with high titre islet-cell antibodies. Pancreas,1996,12:321-333.
  • 6Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 1997,20:1183-1197.
  • 7Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1 : diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med, 1998, 15:539-553.
  • 8Imagawa A, Hanafusa T, Miyagawa J, et al. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. N Engl J Med, 2000, 342:301-307.
  • 9Imagawa A, Hanafusa T, Uchigata Y, et al. Fulminant type 1 diabetes. A nationwide survey in Japan. Diabetes Care, 2003, 26:2345-2352.
  • 10Maldonado MM, Hampe CS, Gaur LK, et al. Ketosis-Prone diabetes : dissection of a heterogeneous syndrome using an immunogenetic and β-cell functional classification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab, 2003,88:5090-5098.

共引文献2358

同被引文献15

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部